NCT05953038View on ClinicalTrials.gov

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

December 18, 2027

Study Completion Date

December 31, 2027

Conditions
Basic Science
Interventions
DRUG

Lysergic Acid Diethylamide Tartrate

D-Lysergic Acid Diethylamide (LSD) D-tartrate as oral drinking solution (water / ethanol 20% m/m)

Trial Locations (1)

2100

Neurobiology Research Unit, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER